Clinical Trial Update: AVEIR Remote Care System Non-Significant Risk Study

View source ↗

Summary

Abbott's AVEIR Remote Care System NSR study has completed; the trial was conducted under a non-significant risk assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Cardiac Arrhythmia

Drugs mentioned

• AVEIR Remote Care System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Cardiac Pacemaker, Cardiac Rhythm Disorder | Status: COMPLETED